The expression of CYP2C (Fisher et al., 2009), CYP2E1 (Bell et al., 2011) and CYP3A4 (Fisher et al., 2009) was upregulated in the liver of the NAFLD model. This evidence concerns the gene CYP3A4 and metabolic dysfunction-associated steatotic liver disease.